Clinical Trials Browser

Locally Advanced Breast Cancer × pertuzumab × Breast × Clear all

NCT03329378 2023-08-22

Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer

Phase 2 Terminated

7 enrolled 10 charts

Locally Advanced Breast Cancer

NCT05749016 2023-03-01

Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer

Phase 2 Unknown

Locally Advanced Breast Cancer